Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action
J Bayry, S Lacroix-Desmazes… - Nature Clinical Practice …, 2007 - nature.com
Advances in our understanding of the pathogenesis of rheumatic diseases such as
rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of …
rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of …
Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action
J Bayry, S Lacroix-desmazes… - Nature Reviews …, 2007 - search.proquest.com
Advances in our understanding of the pathogenesis of rheumatic diseases such as
rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of …
rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of …
[引用][C] Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action
J Bayry, S Lacroix-Desmazes, MD Kazatchkine… - Nature Clinical Practice …, 2007 - cir.nii.ac.jp
Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases:
rationale and mechanisms of action | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
rationale and mechanisms of action | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action
J Bayry, S Lacroix-Desmazes… - Nature clinical …, 2007 - pubmed.ncbi.nlm.nih.gov
Advances in our understanding of the pathogenesis of rheumatic diseases such as
rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of …
rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of …
Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action
J Bayry, S Lacroix-Desmazes… - Nature Clinical …, 2007 - go.gale.com
Advances in our understanding of the pathogenesis of rheumatic diseases such as
rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of …
rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of …
Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.
J Bayry, S Lacroix-Desmazes… - Nature Clinical …, 2007 - europepmc.org
Advances in our understanding of the pathogenesis of rheumatic diseases such as
rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of …
rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of …